Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-005302
Filing Date
2024-02-07
Accepted
2024-02-07 17:56:05
Documents
1
Period of Report
2024-01-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1523
  Complete submission text file 0001493152-24-005302.txt   3068
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5152
FibroBiologics, Inc. (Issuer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 455 E. MEDICAL CENTER BLVD STE 300 HOUSTON TX 77598
Business Address
Andersen Mark C. (Reporting) CIK: 0002010515 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41934 | Film No.: 24606132